ANITA SABICHI

Concepts (409)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with ANITA SABICHI's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that ANITA SABICHI has written about over time.
Anticarcinogenic Agents, 4 publications between 1998 and 2004, average publication date September 2000. Receptors, Retinoic Acid, 3 publications between 1998 and 2005, average publication date August 2002. Fenretinide, 7 publications between 1998 and 2009, average publication date March 2003. Isoenzymes, 5 publications between 2001 and 2004, average publication date May 2003. Prostaglandin-Endoperoxide Synthases, 6 publications between 2001 and 2005, average publication date August 2003. Prostatic Neoplasms, 11 publications between 2000 and 2006, average publication date April 2004. Cyclooxygenase 2, 8 publications between 2001 and 2008, average publication date July 2004. Prostate, 5 publications between 2001 and 2006, average publication date September 2004. Cyclooxygenase 2 Inhibitors, 4 publications between 2003 and 2011, average publication date March 2006. Lung Neoplasms, 7 publications between 1993 and 2022, average publication date May 2006. Urinary Bladder Neoplasms, 21 publications between 1998 and 2017, average publication date August 2006. Carcinoma, Transitional Cell, 10 publications between 2001 and 2011, average publication date January 2007. Antineoplastic Agents, 14 publications between 1998 and 2020, average publication date June 2008. Neoplasm Recurrence, Local, 3 publications between 2007 and 2011, average publication date January 2009. Carcinoma, Squamous Cell, 5 publications between 2003 and 2017, average publication date April 2010. Hepatitis B, Chronic, 4 publications between 2010 and 2020, average publication date July 2015. Drug-Related Side Effects and Adverse Reactions, 1 publications between 2017 and 2017, average publication date March 2017. Myasthenia Gravis, 1 publications between 2017 and 2017, average publication date March 2017. Programmed Cell Death 1 Receptor, 1 publications between 2017 and 2017, average publication date March 2017. Antineoplastic Agents, Immunological, 2 publications between 2017 and 2018, average publication date December 2017.

To see the data from this visualization as text, click here.
SABICHI's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (409)
Explore
_
Co-Authors (22)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_